GILD
Gilead Sciences·NASDAQ
--
--(--)
--
--(--)
GILD fundamentals
Gilead Sciences (GILD) Revenue Breakdown: Q4 2025 Business & Regional Performance
Gilead Sciences (GILD) reported total revenue of 7.92B USD in Q4 2025, with its core business segment Product contributing 99.72%. Regionally, United States remained the largest market, accounting for 74.32% of total revenue. Explore Gilead Sciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Gilead Sciences (GILD) reported total revenue of 7.92B USD in Q4 2025, with its core business segment Product contributing 99.72%. Regionally, United States remained the largest market, accounting for 74.32% of total revenue. Explore Gilead Sciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Gilead Sciences's earnings call?What guidance did Gilead Sciences's management provide for the next earnings period?What is the revenue and EPS growth rate for Gilead Sciences year over year?What factors drove the changes in Gilead Sciences's revenue and profit?What does Gilead Sciences do and what are its main business segments?What were the key takeaways from Gilead Sciences’s earnings call?What is Gilead Sciences's latest dividend and current dividend yield?What is Gilead Sciences's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
